Aura Biosciences Inc

-0.05 (-0.48%)
4:50:43 PM EDT: $10.25 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aura Biosciences Inc Stock, NASDAQ:AURA

80 Guest Street, Boston, Massachusetts 02135
United States of America
Phone: +1.617.500.8864
Number of Employees: 52


Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.